Panel Discussion: Addressing the Unmet Medical Needs in CKD: Defining the Residual Risks & Pathways Forward
Time: 8:30 am
day: Day Two AM
Details:
- Examine the key challenges in identifying CKD patients who continue to face unmet medical needs despite advances in therapy
- Explore how biomarkers and clinical data can highlight patients with residual risk, who remain at risk for disease progression. What is needed to establish standardized criteria for identifying these high-risk patients?
- Which pathways and modes of action that should be prioritized to address unmet needs in CKD from inflammation and fibrosis pathways to alternative MOAs that could close the gaps left by current standard-of-care therapies
- Audience Input